• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于胶囊的干粉吸入器的技术现状:解聚技术及其对制剂雾化的影响

State of the Art in Capsule-Based Dry Powder Inhalers: Deagglomeration Techniques and the Consequences for Formulation Aerosolization.

作者信息

Groß Roman, Berkenfeld Kai, Schulte Christoph, Ebert Anselm, Sule Sunita, Sule Ameet, Lamprecht Alf

机构信息

Laboratory of Pharmaceutical Technology and Biopharmaceutics, Institute of Pharmacy, University of Bonn, Gerhard-Domagk-Street 3, 53121 Bonn, Germany.

Presspart GmbH & Co. KG, Am Meilenstein 8-19, 34431 Marsberg, Germany.

出版信息

Pharmaceutics. 2022 May 31;14(6):1185. doi: 10.3390/pharmaceutics14061185.

DOI:10.3390/pharmaceutics14061185
PMID:35745758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9230934/
Abstract

Commercially available dry powder inhalers (DPIs) are usually devices in a fixed combination with the intended formulation, and a change in medication by the physician often forces the patient to use a different device, requiring the patient to relearn how to use it, resulting in lower adherence and inadequate therapy. To investigate whether DPIs can achieve successful outcomes regardless of the formulation and flow rate used, a novel DPI and two commercially available devices were compared in vitro for their deagglomeration behavior for different binary blends and a spray-dried particle formulation. The results demonstrate that the novel device achieved the highest fine particle fraction (FPF) regardless of the formulations tested. In the binary mixtures tested, the highest emitted fraction was obtained by shaking out the powder due to the oscillating motion of the capsule in the novel device during actuation. For DPIs with high intrinsic resistance to airflow, similar FPFs were obtained with the respective DPI and formulation, regardless of the applied flow rate. Additionally, the development and use of binary blends of spray-dried APIs and carrier particles may result in high FPF and overcome disadvantages of spray-dried particles, such as high powder retention in the capsule.

摘要

市售的干粉吸入器(DPI)通常是与预期制剂固定组合的装置,医生改变用药往往会迫使患者使用不同的装置,这就要求患者重新学习如何使用,从而导致依从性降低和治疗不足。为了研究DPI是否无论使用何种制剂和流速都能取得成功的效果,对一种新型DPI和两种市售装置进行了体外比较,考察它们对不同二元混合物和喷雾干燥颗粒制剂的解聚行为。结果表明,无论测试何种制剂,新型装置都能实现最高的细颗粒分数(FPF)。在测试的二元混合物中,由于新型装置在启动时胶囊的振荡运动,通过抖出粉末获得了最高的喷出分数。对于对气流具有高固有阻力的DPI,无论施加何种流速,使用各自的DPI和制剂都能获得相似的FPF。此外,喷雾干燥的活性药物成分(API)与载体颗粒二元混合物的开发和使用可能会导致高FPF,并克服喷雾干燥颗粒的缺点,如胶囊中粉末保留率高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/ed43cb57844a/pharmaceutics-14-01185-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/2db80f7543d8/pharmaceutics-14-01185-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/b76d1f3e30db/pharmaceutics-14-01185-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/144ba952879c/pharmaceutics-14-01185-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/4100deef8f23/pharmaceutics-14-01185-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/bf7d68799e28/pharmaceutics-14-01185-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/ed43cb57844a/pharmaceutics-14-01185-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/2db80f7543d8/pharmaceutics-14-01185-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/b76d1f3e30db/pharmaceutics-14-01185-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/144ba952879c/pharmaceutics-14-01185-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/4100deef8f23/pharmaceutics-14-01185-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/bf7d68799e28/pharmaceutics-14-01185-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151d/9230934/ed43cb57844a/pharmaceutics-14-01185-g006a.jpg

相似文献

1
State of the Art in Capsule-Based Dry Powder Inhalers: Deagglomeration Techniques and the Consequences for Formulation Aerosolization.基于胶囊的干粉吸入器的技术现状:解聚技术及其对制剂雾化的影响
Pharmaceutics. 2022 May 31;14(6):1185. doi: 10.3390/pharmaceutics14061185.
2
Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.CFD 结合拉格朗日粒子追踪在干粉吸入器中应用的潜力和限制。
Eur J Pharm Sci. 2019 Feb 1;128:299-324. doi: 10.1016/j.ejps.2018.12.008. Epub 2018 Dec 14.
3
Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler.载体制备(甘露醇-乳糖)联合喷雾作为改善硫酸沙丁胺醇干粉吸入剂雾化性能的方法。
Drug Deliv Transl Res. 2020 Oct;10(5):1418-1427. doi: 10.1007/s13346-020-00707-6.
4
Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications.高效干粉吸入器的研发:胶囊腔室设计及吸入器表面改性的影响
Pharm Res. 2014 Feb;31(2):360-72. doi: 10.1007/s11095-013-1165-6. Epub 2013 Aug 16.
5
Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.干粉吸入制剂的气溶胶化特性增强生长(EEG)应用:喷雾干燥工艺条件对气溶胶性能的影响。
Int J Pharm. 2013 Feb 25;443(1-2):137-45. doi: 10.1016/j.ijpharm.2013.01.003. Epub 2013 Jan 10.
6
Development of an Inline Dry Powder Inhaler That Requires Low Air Volume.开发一种需要低空气量的在线干粉吸入器。
J Aerosol Med Pulm Drug Deliv. 2018 Aug;31(4):255-265. doi: 10.1089/jamp.2017.1424. Epub 2017 Dec 20.
7
Overcoming dose limitations using the orbital(®) multi-breath dry powder inhaler.使用奥倍达(®)多剂量干粉吸入器克服剂量限制。
J Aerosol Med Pulm Drug Deliv. 2014 Apr;27(2):138-47. doi: 10.1089/jamp.2013.1080. Epub 2013 Sep 4.
8
Effects of the mouthpiece and chamber of Turbuhaler® on the aerosolization of API-only powder formulations.Turbuhaler®吸嘴和室对仅含 API 粉体配方气溶胶化的影响。
Int J Pharm. 2023 Apr 25;637:122871. doi: 10.1016/j.ijpharm.2023.122871. Epub 2023 Mar 21.
9
The clinical relevance of dry powder inhaler performance for drug delivery.干粉吸入器用于药物递送的性能的临床相关性。
Respir Med. 2014 Aug;108(8):1195-203. doi: 10.1016/j.rmed.2014.05.009. Epub 2014 May 24.
10
Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.开发一种用于儿童口服或经鼻气溶胶给药的在线干粉吸入器。
J Aerosol Med Pulm Drug Deliv. 2020 Apr;33(2):83-98. doi: 10.1089/jamp.2019.1540. Epub 2019 Aug 29.

本文引用的文献

1
(Solvato-) polymorphism of formulations of rifampicin for pulmonary drug delivery prepared using a crystallization/spray drying process.采用结晶/喷雾干燥工艺制备的利福平肺部给药制剂的(溶剂化)多晶型现象。
Int J Pharm. 2020 Nov 30;590:119932. doi: 10.1016/j.ijpharm.2020.119932. Epub 2020 Oct 1.
2
Amorphous solid dispersion dry powder for pulmonary drug delivery: Advantages and challenges.用于肺部递药的无定形固体分散体干粉末:优势和挑战。
Int J Pharm. 2020 Sep 25;587:119711. doi: 10.1016/j.ijpharm.2020.119711. Epub 2020 Jul 30.
3
Inhalable dry powders of rifampicin highlighting potential and drawbacks in formulation development for experimental tuberculosis aerosol therapy.
利福平吸入干粉制剂突出了实验性肺结核气溶胶治疗制剂开发的潜力和缺陷。
Expert Opin Drug Deliv. 2020 Mar;17(3):305-322. doi: 10.1080/17425247.2020.1720644. Epub 2020 Feb 4.
4
Correlations between surface composition and aerosolization of jet-milled dry powder inhaler formulations with pharmaceutical lubricants.喷气磨制干粉吸入器制剂与药用润滑剂的表面成分与气溶胶化之间的相关性。
Int J Pharm. 2019 Sep 10;568:118504. doi: 10.1016/j.ijpharm.2019.118504. Epub 2019 Jul 9.
5
Simultaneous Particle Size Reduction and Homogeneous Mixing to Produce Combinational Powder Formulations for Inhalation by the Single-Step Co-Jet Milling.采用单步共喷射磨技术,同时减小粒径并均匀混合,制备用于吸入的组合粉末配方。
J Pharm Sci. 2019 Sep;108(9):3146-3151. doi: 10.1016/j.xphs.2019.05.011. Epub 2019 May 18.
6
Recent advances in capsule-based dry powder inhaler technology.基于胶囊的干粉吸入器技术的最新进展。
Multidiscip Respir Med. 2017 May 22;12:11. doi: 10.1186/s40248-017-0092-5. eCollection 2017.
7
Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions.思力华能倍乐,一款新型干粉吸入器:模拟真实世界条件下的剂量一致性
J Aerosol Med Pulm Drug Deliv. 2015 Oct;28(5):309-19. doi: 10.1089/jamp.2015.1216. Epub 2015 Sep 9.
8
Formulation Design of Dry Powders for Inhalation.吸入用干粉剂的处方设计
J Pharm Sci. 2015 Oct;104(10):3259-88. doi: 10.1002/jps.24574. Epub 2015 Aug 21.
9
Powder Production and Particle Engineering for Dry Powder Inhaler Formulations.干粉吸入剂制剂的粉末生产与颗粒工程
Curr Pharm Des. 2015;21(27):3902-16. doi: 10.2174/1381612821666150820111134.
10
Dry powder inhalers and the right things to remember: a concept review.干粉吸入器及需牢记的要点:概念综述
Multidiscip Respir Med. 2015 Apr 3;10(1):13. doi: 10.1186/s40248-015-0012-5. eCollection 2015.